|
|
| 2.59 Data as of Dec 06 |  +0.03 / +1.17%Today’s Change | 1.55 Today|||52-Week Range 5.10 | +2.37% Year-to-Date |
| Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews Dec 03 / Zacks.com | New Data on BioLineRx BL-7040 - Analyst Blog Nov 27 / Zacks.com |
| Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook Dec 03 / Zacks.com |
| Previous close | 2.56 |
| Today’s open | 2.59 |
| Day’s range | 2.48 - 2.60 |
| Volume | 72,702 |
| Average volume (3 months) | 115,420 |
| Market cap | $61.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ORMPOramed Pharmaceutica... | -0.09 | -1.14% |
| OPLIOphthalix Inc | 0.00 | 0.00% |
| ANTHAnthera Pharmaceutic... | -0.05 | -1.70% |
| VTUSVentrus Biosciences ... | +0.04 | +1.32% |
| Next reporting date | March 11, 2014 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
.
